Skip to content
  • About Us
    • Management
    • Board of Directors
    • Clinical and Scientific Advisory Board
  • Careers
  • Lead Technology
  • Publications
  • Investors
  • Contact Us
Menu
  • About Us
    • Management
    • Board of Directors
    • Clinical and Scientific Advisory Board
  • Careers
  • Lead Technology
  • Publications
  • Investors
  • Contact Us
Search
Close
A New Flu Drug Works Astoundingly Well—By Not Targeting the Flu at All

A New Flu Drug Works Astoundingly Well—By Not Targeting the Flu at All

  • Post author:gtmrick
  • Post published:June 13, 2015
  • Post category:Uncategorized

A New Flu Drug Works Astoundingly Well—By Not Targeting the Flu at All. Continue reading at Motherboard Vice.

Continue Reading A New Flu Drug Works Astoundingly Well—By Not Targeting the Flu at All
Preventing the flu: Researchers looking for a new approach

Preventing the flu: Researchers looking for a new approach

  • Post author:gtmrick
  • Post published:June 5, 2015
  • Post category:Uncategorized

Lifetime: New approach to fighting influenza Advertise on CTVNews.ca

Continue Reading Preventing the flu: Researchers looking for a new approach

Recent Posts

  • Vasomune and AnGes Announce First Patient Enrolled in Phase 2a Clinical Study Evaluating AV-001 for the Treatment of Severe COVID-19 Disease
  • Vasomune Announces Government Financial Support for the Development of COVID-19 Therapeutic
  • Vasomune Announces Preliminary Positive Phase 1 Clinical Trial Results for Vascular Normalization Therapy
  • Vasomune is Pleased to Announce the Government of Canada’s Investment in AV-001 Targeting COVID-19
  • Vasomune Announces Initiation of the First-in-Human Clinical Trial of a Potential Vascular Normalization COVID-19 Treatment

Recent Comments

    Archives

    • January 2022
    • November 2021
    • March 2021
    • December 2020
    • November 2020
    • August 2020
    • May 2020
    • March 2020
    • February 2020
    • January 2020
    • August 2018
    • December 2017
    • June 2015

    Categories

    • Press Release
    • Uncategorized

    Meta

    • Log in
    • Entries feed
    • Comments feed
    • WordPress.org

    About

    Vasomune Therapeutics is a private biotechnology company developing the next generation of medications to harness the body’s ability to defend against illness by modifying cellular response to disease.

    Vasomune Therapeutics 2020 © All Rights Reserved.